Epidemiology and psychopharmacology of anxiety in medical patients

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 7, 1996, Pages 64-72

  Stoudemire, Alan ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY NEUROSIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; GASTROINTESTINAL DISEASE; HUMAN; LUNG DISEASE; PANIC; PRIORITY JOURNAL; RISK FACTOR; SKIN DISEASE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; BUSPIRONE; COMORBIDITY; EPIDEMIOLOGY; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PREVALENCE;

EID: 0029757677     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (107)

1. Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry 1989;146:1440-1446
2. Goldberg RJ, Posner DA. Anxiety in the medically ill. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:87-104
3. Wise MG, Rieck SO. Diagnostic considerations and treatment approaches to underlying anxiety in the medically ill. J Clin Psychiatry 1993;54(5, suppl):22-26
4. Cassem NH, Hackett TP. Psychological rehabilitation of myocardial infarction patients in the acute phase. Heart Lung 1973;2:382-388
5. Beitman B, Basha I, Flaker G, et al. Atypical or nonanginal chest pain: panic disorder or coronary artery disease? Arch Intern Med 1987;147: 1548-1552
6. Beitman B, Mukerji V, Lamberti J, et al. Panic disorder in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 1989;63:1399-1403
7. Coryell W, Noyes R, Clancy J. Excess mortality in panic disorder. Arch Gen Psychiatry 1982;39:701-703
8. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ 1987;295:297-299
9. Kahn JP, Drusin RE, Klein DF. Idiopathic cardiomyopathy and panic disorder: clinical association in cardiac transplant candidates. Am J Psychiatry 1987;144:1327-1330
10. Logue MB, Thomas AM, Barbee JG, et al. Generalized anxiety disorder patients seek evaluation for cardiological symptoms at the same frequency as patients with panic disorder. J Psychiatr Res 1993;27:55-59
11. Kane FJ, Harper RG, Wittels E. Angina as a symptom of psychiatric illness. South Med J 1988;81:1412-1416
12. Derogatis LR. Brief Symptom Inventory. Baltimore, Md: Johns Hopkins University Press; 1979
13. Carter C, Maddock R. Chest pain in generalized anxiety disorder. Int J Psychiatry Med 1992;22:291-298
14. Wulsin LR, Arnold LM, Hillard JR. Axis I disorders in ER patients with atypical chest pain. Int J Psychiatry Med 1991;21:37-46
15. Goldstein MG, Niaura R. Cardiovascular disease, I: coronary artery disease and sudden death. In: Stoudemire A, ed. Psychological Factors Affecting Medical Conditions. Washington, DC: American Psychiatric Press; 1995:19-37
16. Niaura R, Goldstein MG. Cardiovascular disease, II: coronary artery disease and sudden death and hypertension. In: Stoudemire A, ed. Psychological Factors Affecting Medical Conditions. Washington, DC: American Psychiatric Press; 1995:39-56
17. Blumenthal JA, Bradley W, Dimsdale JE, et al. Task Force III: assessment of psychological status in patients with ischemic heart disease. J Am Coll Cardiol 1989;14:1034-1042
18. Deanfield J, Kensett M, Wilson R, et al. Silent myocardial ischemia due to mental stress. Lancet 1984;2:1001-1004
19. Helmers K, Krantz D, Howell R, et al. Hostility and myocardial ischemia in coronary artery disease patients: evaluation by gender and ischemic index. Psychosom Med 1993;55:29-36
20. Myrtek M, Fichtler A, Konig K, et al. Differences between patients with asymptomatic and symptomatic myocardial infarction: the relevance of psychological factors. Eur Heart J 1994;15:311-317
21. Selwyn A, Gantz P. Myocardial ischemia in coronary disease. N Engl J Med 1988;318:1058-1060
22. Barry J, Selwyn A, Nabel E. Frequency of ST segment depression produced by mental stress in stable angina pectoris from coronary artery disease. Am J Cardiol 1988;61:989-993
23. Rozanski A, Bairey C, Krantz D, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988;318:1005-1012
24. Williams RJ. Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders? J Psychiatr Res 1990;24(suppl 2):51-56
25. Kawachi I, Colditz G, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89: 1992-1997
26. Dorian B, Taylor C. Stress factors in the development of coronary artery disease. J Occup Med 1984;26:747-756
27. Fricchione G, Vlay S. Psychiatric aspects of patients with malignant ventricular arrhythmias. Am J Psychiatry 1986;143:1518-1526
28. Greene W, Goldstein S, Moss A. Psychosocial aspects of sudden cardiac death. Arch Intern Med 1972;129:725-731
29. Kamarck T, Jennings J. Biobehavioral factors in sudden cardiac death. Psychol Bull 1991;109:42-75
30. Myers A, Dewar N. Circumstances attending 100 sudden deaths from coronary artery disease with coroner's necropsies. Br Heart J 1975;37: 1133-1143
31. Reich P, DeSilva R, Lown B, et al. Acute psychological disturbance preceding life-threatening ventricular arrhythmia. JAMA 1981;246:233-235
32. Siltanen P. Life changes and sudden coronary death. Adv Cardiol 1978;25: 47-60
33. Tavazzi L, Zotti A, Rondanelli R. The role of psychologic stress in the genesis of lethal arrhythmias in patients with coronary artery disease. Eur Heart J 1986;7(suppl A):99-106
34. Schwartz PJ. Stress and sudden cardiac death: the role of the autonomic nervous system. J Clin Psychiatry Monograph 1984;2(1):7-13
35. Lown B, DeSilva R. Roles of psychologic stress and autonomic nervous system changes in provocation of ventricular premature complexes. Am J Cardiol 1978;41:979-985
36. Karajgi B, Rifkin A, Doddi S, et al. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 1990;147:200-201
37. Yellowlees P, Alpers J, Bowden J, et al. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 1987;146:305-307
38. Zandbergen J, Bright M, Pols H, et al. Higher lifetime prevalence of respiratory diseases in panic disorder? Am J Psychiatry 1991;148:1583-1585
39. Craven J. Psychiatric aspects of lung transplant. Can J Psychiatry 1990;35: 759-764
40. Gorman J, Fuer M, Goetz R, et al. Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 1988;45:31-39
41. Yellowlees P, Haynes S, Potts N, et al. Psychiatric morbidity in patients with life-threatening asthma: initial report of a controlled study. Med J Aust 1988;149:246-249
42. Yellowlees P, Ruffin R. Psychological defences and coping styles in patients following a life threatening attack of asthma. Chest 1989;95: 1298-1303
43. de Ruiter C, Garssen B, Rijken H, et al. The hyperventilation syndrome in panic disorder, agoraphobia and generalized anxiety disorder. Behav Res Ther 1989;27:447-452
44. Rapee R. Differential response to hyperventilation in panic disorder and generalized anxiety disorder. J Abnorm Psychol 1986;95:24-28
45. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980
46. Starkstein SE, Cohen BS, Fedoroff P, et al. Relationship between anxiety disorders and depressive disorders in patients with cerebrovascular injury. Arch Gen Psychiatry 1990;47:246-251
47. Morris PL, Robinson RG, Raphael B. The prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med 1990;20: 349-364
48. House A, Dennis M, Mogridge L, et al. Mood disorders in the year after stroke. Br J Psychiatry 1991;158:83-92
49. Fedoroff JP, Starkstein SE, Parikh RM, et al. Are depressive symptoms nonspecific in patients with acute stroke? Am J Psychiatry 1991;148: 1172-1176
50. Burvill P, Johnson G, Jamrozik K, et al. Anxiety disorders after stroke: results from the Perth Community Stroke Study. Br J Psychiatry 1995;166: 328-332
51. Weissman MM, Markowitz JS, Ouellette R, et al. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 1990;147:1504-1508
52. Lydiard RB, Laraia MT, Howell EF, et al. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry 1986;47:470-473
53. Noyes R Jr, Cook B, Garvey M, et al. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990;31: 75-79
54. Lydiard RB, Fossey MD, Ballenger JC. Irritable bowel syndrome in patients with panic disorder [letter]. Am J Psychiatry 1991;148:1614
55. Lydiard RB, Greenwald S, Weissman MM, et al. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area Project. Am J Psychiatry 1994;151:64-70
56. Tollefson GD, Luxenberg M, Valentine R, et al. An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. J Clin Psychiatry 1991;52:502-508
57. Olden K, Jenike M, Baer L. Is irritable bowel syndrome related to OCD? In: New Research Program and Abstracts of the 146th Annual Meeting of the American Psychiatric Association; May 25, 1993; San Francisco, Calif. Abstract NR369:151
58. Felliti V. Long-term medical consequences of incest, rape and molestation. South Med J 1991;84:328-331
59. Drossman DA, Leserman J, Nachman G, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990;113:828-833
60. Walker EA, Katon WJ, Roy BP, et al. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry 1993;150:1502-1506
61. Scarinci I, Haile J, Bradley L, et al. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse. Am J Med 1994;97:105-107
62. Lydiard RB. Psychopharmacological interventions for functional bowel disease. In: Olden KW, ed. Functional Gastrointestinal Disorders: A Biopsychosocial Approach. New York, NY: Dekker. In press
63. Lustman PJ, Griffith LS, Clouse RE, et al. Psychiatric illness in diabetes mellitus: relationship to symptoms and glucose control. J Nerv Ment Dis 1986;174:736-742
64. Popkin MK, Callies AL, Lentz RD, et al. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry 1988;45:64-70
65. Lustman PJ. Anxiety disorders in adults with diabetes mellitus. Psychiatr Clin North Am 1988;11:419-432
66. Lampic C, Wennberg A, Schill J. Anxiety and cancer-related worry of cancer patients at routine follow-up visits. Acta Oncol 1994;33:119-125
67. Jacobsen PB, Bovbjerg DH, Redd WH. Anticipatory anxiety in women receiving chemotherapy for breast cancer. Health Psychol 1993;12:469-475
68. Lesko LM, Massie MJ, Holland J. Oncology. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:565-590
69. Gupta MA. Dermatology. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:681-690
70. Koo JYM. Psychotropic agents in dermatology. Dermatologic Therapy 1993;11:215-224
71. Stein MB, Heuser IJ, Juncos JL, et al. Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry 1990;147:217-220
72. Tarter RE, Hays AL, Carra J, et al, Sjögren's syndrome: its contribution to neuropsychiatric syndrome in patients with primary biliary cirrhosis. Dig Dis Sci 1989;34:9-12
73. Fossey MD, Lydiard RB. Anxiety and the gastrointestinal system. Psychiatric Medicine 1990;8:175-186
74. Stewart WS, Linet M, Calentano DD. Migraine headaches and panic attacks. Psychosom Med 1989;51:559-569
75. Wise MG, Griffies WS. A combined treatment approach to anxiety in the medically ill. J Clin Psychiatry 1995;56(suppl 2):14-19
76. Stoudemire A, Moran MG. Psychopharmacologic treatment of anxiety in the medically ill elderly patient: special considerations. J Clin Psychiatry 1993;54(5, suppl):27-33
77. Dalhoff K, Poulsen HE, Garred P, et al. Buspirone pharmacokinetics in patients with cirrhosis. Br J Clin Pharmacol 1987;24:547-550
78. Goa KL, Ward A. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 1986;32:114-129
79. Gammans RE, Westrick ML, Shea JP, et al. Pharmacokinetics of buspirone in elderly subjects. J Clin Pharmacol 1989;29:72-78
80. Molitor JA, Gammans RE, Carroll CM, et al. Effect of buspirone on mixed function oxidase in rats [abstract]. Federation Proceedings 1985;44:1257
81. Sussman N. Treatment of anxiety with buspirone. Psychiatric Annals 1987;17:114-117
82. Funck-Brentano C. Topics in clinical pharmacology: buspirone: a new nonbenzodiazepine anxiolytic agent. Am J Med Sci 1989;297:49-52
83. Garner SJ, Eldridge FL, Wagner PG, et al. Buspirone, an anxiolytic drug that stimulates respiration. Am Rev Respir Dis 1989;139:946-950
84. Stoudemire A, Fogel BS, Gulley LR. Psychopharmacology in the medically ill: an update. In: Stoudemire A, Fogel BS, eds. Medical-Psychiatric Practice, vol 1. Washington, DC: American Psychiatric Press; 1991:29-98
85. Kiev A, Domantay AG. A study of buspirone coprescribed with bronchodilators in 82 anxious ambulatory patients. J Asthma 1988; 25:281-284
86. Levine A. Buspirone and agitation in head injury. Brain Inj 1988;2: 165-167
87. Colenda CC. Buspirone in treatment of agitated demented patients [letter]. Lancet 1988;1:1169
88. Tiller JWG, Dakis JA, Shaw JM. Short-term buspirone treatment in disinhibition with dementia [letter]. Lancet 1988;2:510
89. Robinson D, Napoliello MJ, Schenk J. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients. Clin Ther 1988;10:740-746
90. Hirsch DA, Fishman J, Breitbart W, et al. Buspirone treatment for anxiety in HIV infection. In: New Research Program and Abstracts of the 143rd Annual Meeting of the American Psychiatric Association; May 17, 1990; New York, NY. Abstract NR580:272
91. Liebowitz MR, Fyer AJ, Gorman JM, et al. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. J Psychiatr Res 1988;22(suppl 1):7-31
92. Kahn RJ, McNair DM, Lipman RS, et al. Imipramine and chlordiazepoxide in depressive and anxiety disorders, II: efficacy in anxious outpatients. Arch Gen Psychiatry 1986;43:79-85
93. Johnstone EC, Owens DG, Frith CD, et al. Neurotic illness and its response to anxiolytic and antidepressant treatment Psychol Med 1980; 10:321-328
94. Stoudemire A, Fogel BS, Gulley LR, et al. Psychopharmacology in the medical patient. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:155-206
95. Stoudemire A. New antidepressants and the treatment of depression in the medically ill patient. Psychiatr Clin North Am. In press
96. Stoudemire A, Fogel BS. Psychopharmacology in the medical patient: an update. In: Stoudemire A, Fogel BS, eds. Medical-Psychiatric Practice, vol 3. Washington, DC: American Psychiatric Press; 1995:79-149
97. Small GW. Tricyclic antidepressants for medically ill geriatric patients. J Clin Psychiatry 1989;50(7, suppl):27-31
98. Stoudemire A, Moran MG, Fogel BS. Psychotropic drug use in the medically ill, part I. Psychosomatics 1990;31:377-391
99. Stoudemire A, Moran MG, Fogel BS. Psychotropic drug use in the medically ill, part II. Psychosomatics 1991;32:34-46
100. Stoudemire A, Fogel BS. Psychopharmacology in the medically ill. In: Stoudemire A, Fogel BS, eds. Principles of Medical Psychiatry. Orlando, Fla: Grune & Stratton; 1987:79-112
101. Cutler NR, Narang PK. Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics. Psychiatr Clin North Am 1984;7:845-861
102. Tyrer P. Current status of β-blocking drugs in the treatment of anxiety disorders. Drugs 1988;36:773-783
103. 1-selectivity and intrinsic sympathomimetic activity in a β-adrenergic blocking drug. Am J Cardiol 1987;59:33F-37F
104. Frishman WH. Clinical differences between β-adrenergic blocking agents: implications for therapeutic substitution. Am Heart J 1987;113: 1190-1198
105. Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gilman AG, Goodman LS, Rall TW, et al, eds. The Pharmacological Basis of Therapeutics. 7th ed. New York, NY: Macmillan; 1985:605-638
106. Gengo FM, Gabos C, Mechtler L. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. Ann Allergy 1990;64:520-526
107. Meador KJ, Loring DW, Thompson EE, et al. Differential cognitive effects of terfenadine and chlorpheniramine. J Allergy Clin Immunol 1989; 84:322-325